• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Why an exec at biopharma giant Gilead Sciences prefers energy management over time management
C-SuiteWhy an exec at biopharma giant Gilead Sciences prefers energy management over time management
By Ruth UmohApril 13, 2026
Albert Bourla
SuccessOnly one U.S. university ranks in the world’s top 10 in STEM. Pfizer’s CEO is calling for change
By Preston ForeApril 3, 2026
kennnedy
CommentaryAmerica is handing its mRNA lead to China—and RFK Jr. is to blame
By Jeff CollerMarch 26, 2026
bakker
CommentaryThe $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients
By Annette Bakker and Andrew W. LoMarch 19, 2026
TrumpRx
CommentaryTrumpRx is here and it helps, though a bit less than advertised
By Jeffrey Sonnenfeld, Stephen Henriques, Ferron Chen, Asuka Koda and Vanessa McLennanFebruary 11, 2026
hudson
CommentarySanofi CEO: The enterprise AI shift will reshape pharma in 2026
By Paul HudsonFebruary 10, 2026
Hims & Hers scraps copycat Wegovy weight-loss pill after probe
North AmericaHims & Hers scraps copycat Wegovy weight-loss pill after probe
By Jessica Nix, Madison Muller and BloombergFebruary 7, 2026
How Pfizer’s CEO wielded moral clarity to help his team do the impossible
C-SuiteHow Pfizer’s CEO wielded moral clarity to help his team do the impossible
By Ruth UmohFebruary 2, 2026
Albert Bourla
SuccessPfizer CEO Albert Bourla’s best leadership advice: Being optimistic is better than being right
By Preston ForeJanuary 31, 2026
‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
C-Suite‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
By Nick LichtenbergJanuary 30, 2026
As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
HealthAs billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
By Marco Quiroz-GutierrezJanuary 30, 2026
Walmart doubles down on health, promoting 3,000 pharmacy workers and upping earning potential—with no college degree required
Workplace CultureWalmart doubles down on health, promoting 3,000 pharmacy workers and upping earning potential—with no college degree required
By Sydney LakeJanuary 29, 2026
Graphic reads: Fortune Titans and Disruptors of Industry with Albert Bourla, CEO of Pfizer, Hosted by Alyson Shontell (both pictured).
C-SuitePfizer CEO on how he struck a deal with President Trump in 10 days to lower American drug costs
By Fortune EditorsJanuary 27, 2026
hassabis
InvestingInside Big Pharma and VC’s big bet on AI: You wouldn’t ‘want to fly an airplane designed by hand, but all of our drugs are designed like that’
By Nick LichtenbergJanuary 23, 2026
AI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science
AIAI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science
By Nicholas GordonJanuary 22, 2026
1
  • 1
  • 2
  • 3
  • 4
  • 5
...100
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
AI
‘The cost of compute is far beyond the costs of the employees’: Nvidia executive says right now AI is more expensive than paying human workersplaceholder alt text
By Sasha RogelbergApril 28, 2026
Energy
‘Take the money and run’: Johns Hopkins economist Steve Hanke on why the UAE quit OPECplaceholder alt text
By Shawn TullyApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.